天癸散敷贴治疗2型糖尿病伴骨量减少的疗效及其对TGF-β1水平的影响OA
Efficacy of Tiangui Powder in the Treatment of Type 2 Diabetes with Osteopenia and Its Effect on TGF-β1 Level
目的:探讨天癸散对2型糖尿病(T2DM)伴骨量减少患者的疗效及对转化生长因子β1(TGF-β1)水平的影响.方法:选取符合诊断标准的T2DM伴骨量减少患者65例,采用分层区组随机法分为天癸散组和基础治疗组,每组各30例(脱落5例).天癸散组患者在基础治疗(降糖、补钙及维生素D)基础上加用天癸散穴位敷贴(神阙、肾俞、关元、足三里),每日1次,每次6h,疗程3个月;基础治疗组患者仅接受基础治疗及模拟敷贴.治疗前后检测腰椎骨密度(BMD)、视觉模拟评分法(VAS)、糖代谢指标(FBG、HbA1c)、骨代谢标志物(ALP、P1NP、N-MID、β-CTX)及血清TGF-β1 水平,并依据综合疗效评定标准评估疗效.结果:治疗后,天癸散组患者VAS评分较基础治疗显著降低(t=-2.55,P=0.014),FBG与HbA1c改善优于基础治疗组患者.骨形成标志物P1NP、N-MID显著升高,血清TGF-β1 水平较治疗前显著上升.结论:天癸散敷贴可改善T2DM伴骨量减少患者疼痛及糖代谢,并可能通过调节TGF-β1 参与骨代谢过程.
Objective:To investigate the therapeutic effect of Tiangui Powder on patients with type 2 diabetes mellitus(T2DM)complicated with reduced bone mass,and its influence on the level of transforming growth factor-β1(TGF-β1).Methods:A to-tal of 65 patients diagnosed with T2DM and reduced bone mass were enrolled and randomly assigned into the Tiangui Powder and the basic treatment group using stratified block randomization,with 30 cases in each group after 5 dropouts.The Tiangui Powder received standard treatment(hypoglycemic therapy,calcium,and vitamin D supplementation)combined with acupoint application of Tiangui Powder at Shenque(CV8),Shenshu(BL23),Guanyuan(CV4),and Zusanli(ST36),once daily for 6 hours each time,over a course of 3 months.The basic treatment group received only standard treatment and placebo applica-tion.Before and after treatment,lumbar bone mineral density(BMD),visual analogue scale(VAS)score,glucose metabolism indicators(fasting blood glucose[FBG],glycated hemoglobin[HbA1c]),bone metabolic markers(alkaline phosphatase[ALP],procollagen type I N-terminal propeptide[P1NP],N-mid osteocalcin[N-MID],β-C-terminal telopeptide of type I col-lagen[β-CTX]),and serum TGF-β1 levels were assessed.Clinical efficacy was evaluated based on comprehensive efficacy cri-teria.Results:After treatment,the VAS score in the Tiangui Powder was significantly lower than that in the basic treatment group(t=-2.55,P=0.014).Improvements in FBG and HbA1c were also superior in the Tiangui Powder.The levels of bone formation markers P1NP and N-MID significantly increased,and the serum TGF-β1 level was markedly elevated com-pared with pre-treatment levels.Conclusion:Acupoint application of Tiangui Powder can alleviate pain and improve glucose metabolism in patients with T2DM and reduced bone mass,potentially by modulating TGF-β1 levels and promoting bone me-tabolism.
阮茶梅;林晓生
广州中医药大学 深圳中西医结合临床医学院,广东 深圳 518104||广州中医药大学,广东 广州 511400广州中医药大学,广东 广州 511400||深圳市宝安区中心医院,广东 深圳 518100
医药卫生
天癸散2型糖尿病骨量减少TGF-β1中医药治疗
Tiangui PowderType 2 Diabetes MellitusReduced Bone MassTGF-Β1Traditional Chinese Medicine Therapy
《亚太传统医药》 2026 (3)
46-51,6
深圳市宝安区中医药临床研究专项(2023ZYYLCZX-2)广东省深圳市基础研究专项(自然科学基金)基础研究面上项目(JCYJ20240813103617024)广东省中医药管理局项目(20251333)深圳市"医疗卫生三名工程"项目(SZZYSM202311017)
评论